Loading...

Raia Drogasil S.A.

RADLY•PNK
Healthcare
Medical - Pharmaceuticals
$4.34
$-0.28(-6.06%)
U.S. Market is Open • 13:17

Raia Drogasil S.A. (RADLY) Stock Overview

Explore Raia Drogasil S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8B
P/E Ratio30.03
EPS (TTM)$0.16
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$4.76
3 Months$6.10
1 Year Target$2.73

RADLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Raia Drogasil S.A. (RADLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.03 and a market capitalization of 8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.52%
5-Day Change
-1.09%
1-Month Change
-5.60%
3-Month Change
-9.72%
6-Month Change
17.88%
Year-to-Date (YTD) Change
-2.15%
1-Year Change
31.50%
3-Year Change
-19.89%
5-Year Change
-8.63%
All-Time (Max) Change
18.49%

Contact Information

https://www.rd.com.br
55 11 3769 5678
Av. Corifeu de Azevedo Marques, 3097, São Paulo, SP, 05.339-900

Company Facts

66,275 Employees
IPO DateJul 19, 2016
CountryBR
Actively Trading

Frequently Asked Questions